A fifth of annual suspected UK prostate cancer referrals could be fast-tracked for investigation, while another 40 per cent could avoid referral and invasive biopsies if genetic risk was included in triage.A fifth of annual suspected UK prostate cancer referrals could be fast-tracked for investigation, while another 40 per cent could avoid referral and invasive biopsies if genetic risk was included in triage.Read MoreHealth News | Mail Online